G1 Therapeutics, Inc.
(NYSE: GTHX)
Rigrodsky Law, P.A. is investigating G1 Therapeutics, Inc. (“G1”) regarding possible breaches of fiduciary duties and other violations of law related to G1’s agreement to be acquired by Pharmacosmos A/S. Under the terms of the agreement, G1 shareholders will receive $ 7.15 per share in cash.